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Abstract
Disseminated cancer cells that have extravasated into the tissue parenchyma must interact
productively with its extracellular matrix (ECM) components in order to survive, proliferate and
form macroscopic metastases. The biochemical and cell-biological mechanisms enabling this
interaction remain poorly understood. We find that the formation of elongated, integrin β1-
containing adhesion plaques by cancer cells that have extravasated into the lung parenchyma
enables the proliferation of these cells via activation of focal adhesion kinase (FAK). These
plaques originate in and appear only after the formation of filopodium-like protrusions (FLPs) that
harbor integrin β1 along their shafts. The cytoskeleton-regulating proteins Rif and mDia2
contribute critically to the formation of these protrusions and thereby enable the proliferation of
extravasated cancer cells. Hence, the formation of FLPs represents a critical rate-limiting step for
the subsequent development of macroscopic metastases.
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Introduction
Hematogenous metastasis, the major cause of cancer-associated mortality, proceeds through
the dissemination of cancer cells from the primary tumor via the circulation. The circulating
cells eventually lodge in the capillary beds of distant organs, from which they may
extravasate into the adjacent tissue parenchyma (1). The majority of extravasated cells either
quickly undergo apoptosis or persist in the parenchyma of host tissue in a viable but non-
proliferating state, and only rarely do they succeed in colonization, i.e., in generating
macroscopic growths within such tissues (2, 3). The inability of cancer cells to survive and
proliferate following extravasation appears to be attributable, in part, to the difficulties that
these cells experience in adapting to the novel tissue microenvironments in which they have
landed (4, 5). These microenvironments are likely defined by complex mixtures of growth
factors, cytokines, and extracellular matrix (ECM) components (6).
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We and others have studied the behavior of cancer cells disseminated in the lung
parenchyma using a set of three mouse mammary carcinoma cell lines – D2.0R, D2.1 and
D2A1 – with differing potentials for metastasis (7–10). When introduced into mice via tail-
vein injection, all three cell populations extravasate into the lung parenchyma with
comparable efficiency and exhibit similar rates of initial survival (10). However, they show
marked differences in subsequent proliferation and colony formation: the D2A1 cells
proliferate rapidly after extravasation and colonize the lung tissue effectively, while the
D2.0R and D2.1 cells fail to do so (10).
In the earlier studies, we and others undertook to model the post-extravasation behavior of
the various D2 cell lines using an in vitro model system (9, 10). Thus, these cells were
propagated in three-dimensional (3D) culture using the “Matrigel on-top (MoT)” method
(11), in which cells are plated above a layer of undiluted Matrigel and then covered with
Matrigel diluted 1:50 with culture medium. In our own case, these cells were prepared as
single-cell suspensions and seeded at low densities (500–2000 cells/cm2 bottom area; ref.
10). This ensured that individual cells were initially surrounded on all sides by ECM
components, which modeled the conditions encountered by cancer cells immediately after
extravasating into the lung parenchyma.
While these MoT conditions recapitulated only limited aspects of the in vivo
microenvironment, they sufficed to reproduce the differing proliferation rates of the various
D2 cell populations in the lungs. Thus, the D2A1 cells, which are far more aggressive in
vivo, proliferated far more rapidly under MoT conditions than did the other two
nonaggressive D2 cell types (9, 10). This contrasted with the behavior of these three cell
types in monolayer culture, where they proliferated equally well (9, 10).
Subsequent analyses revealed that integrin-mediated interactions with the ECM proteins are
essential for the aggressive D2A1 cells to proliferate rapidly both under MoT culture
conditions and within the lung parenchyma (10). We also found that integrins containing the
β1 subunit contribute critically to these interactions, which confirmed previously reported
observations by others (9, 12), and that these interactions ultimately enable rapid cell
proliferation by triggering intracellular signaling events including the activation of focal
adhesion kinase (FAK) (10).
In the present study, we identify the processes exploited by the recently extravasated,
micrometastatic cancer cells in the lungs to establish productive interactions with the
surrounding ECM. In brief, these processes begin with the formation of thin, actin-rich
protrusions that harbor integrin β1 together with other proteins that collaborate with
integrins to form cell-matrix adhesions. These protrusions support the initial interactions
between the extravasated cancer cells and ECM components of the lung parenchyma,
thereby helping these cells to trigger adhesion-dependent signaling events including FAK
activation. The resulting active FAK signaling, in turn, phosphorylates and activates
extracellular signal-regulated kinases (ERKs) and thereby enables rapid proliferation of
these cancer cells within the lung tissue.
Results
FAK/ERK signaling as a critical trigger for the post-extravasation proliferation
We undertook to elucidate the molecular basis for the differing proliferation rates of the
various D2 cell populations, which were observed both when these cells were growing in
MoT cultures and following their extravasation into the lung parenchyma (Supplementary
Figs. S1A–E). This led us to discover the critical role of FAK-dependent activation of the
ERKs – central mediators of various proliferation-promoting signals (13) – in determining
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the proliferation rates under these conditions (ref. 10; Fig. 1A and Supplementary Figs.
S2A–D).
Thus, FAK knockdown in the otherwise-aggressive D2A1 cells impaired their proliferation
under MoT culture conditions, which was associated with a strong reduction in the
phosphorylation of ERKs at residues critical to their activity (Fig. 1A). Working in the
opposite direction, the ectopic expression of the constitutively-active CD2-FAK fusion
protein in the otherwise-nonaggressive D2.0R and D2.1 cells elevated ERK phosphorylation
levels and allowed these cells to proliferate rapidly under the MoT culture conditions
(Supplementary Figs. S2A and S2B). Importantly, FAK signaling also contributed to ERK
activation and thus to proliferation in vivo shortly after these cells had extravasated into the
lung parenchyma (Figs. 1A, 1B and Supplementary Fig. S2D). In contrast, manipulation of
FAK signaling did not discernibly affect either ERK phosphorylation levels or the
proliferation rates when these various cell populations were growing as monolayers in vitro
(Fig. 1A and Supplementary Figs. S2A–C).
We also found that the degree of the activation-associated phosphorylation of FAK and
ERKs correlated closely with the abilities of the various populations of D2 cells to
proliferate both under the MoT conditions of culture and within the lung parenchyma (ref.
10; Supplementary Figs. S3A–C). Taken together, these observations indicated that the
activation status of FAK governed the activity of ERKs and thus critically determined the
rate of cell proliferation under both conditions (Supplementary Fig. S3C). These
observations prompted us to study the mechanisms that control FAK activation in cells
growing under the MoT conditions of culture as well as in those that have extravasated into
the lung parenchyma.
Assembly of elongated adhesion plaques as a controller of FAK signaling
We initially focused on the control of FAK phosphorylation in cells growing under in vitro
MoT culture. Recruitment by ECM-ligated integrins is known to be crucial for the efficient
phosphorylation and resulting activation of FAK (14). Moreover, we previously identified
integrin β1 as an integrin subunit essential for FAK activation in MoT-cultured D2A1 cells.
Indeed, the knockdown of integrin β1 expression in these cells diminished both
autophosphorylation of FAK on its tyrosine residue 397 (Y397) and Src-mediated
phosphorylation on tyrosine residue 861 (Y861) (10); both Y397 and Y861 are important
phosphorylation sites for the FAK-dependent activation of multiple signaling events (14).
We also noted that the three D2 cell populations exhibited strikingly different patterns of
integrin β1 distribution under MoT culture conditions: in the majority of the aggressive
D2A1 cells, abundant integrin β1-containing, elongated adhesion plaques were assembled,
while in the more indolent D2.0R and D2.1 cells, integrin β1 was distributed evenly near the
contact sites between Matrigel and the plasma membrane (ref. 10; Fig. 1C, Supplementary
Figs. S4, S5A–C, S6A and S6B). The elongated morphology of adhesion plaques formed by
the D2A1 cells is typical of the mature form of these plaques. Thus, earlier studies of
fibroblasts growing in monolayer culture revealed that adhesions to ECM initially appear as
small dots at the cell periphery, termed focal complexes. These dots are converted
subsequently into ones having an oval-like or elongated morphology, which is often
associated with the activation of a variety of signaling events (15).
We wished to determine whether the formation of these elongated adhesion plaques was
accompanied by the activation of important signaling events, more specifically the
phosphorylation of FAK, in the MoT-cultured D2A1 cells. In individual cells, we observed
two distinct patterns of integrin β1 accumulation: the majority of these cells displayed
localization of integrin β1 to elongated adhesion plaques, while the remaining cells exhibited
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an even distribution of this integrin subunit near the plasma membrane (“peripheral
accumulations”; Fig. 1D). We proceeded to measure the levels of FAK phosphorylation
associated with each of these two patterns of integrin β1 accumulation by immunostaining
the cells for both integrin β1 and phosphorylated FAK. This revealed that the ratio of pFAK-
staining intensity to that of integrin β1-staining was higher in the elongated plaques than in
the peripheral accumulations, by 2.5 and 2.1 fold for pFAK [Y397] and pFAK [Y861],
respectively (Fig. 1D). Hence, elongated plaque formation was correlated directly with
elevated phosphorylation and thus activation of FAK.
In addition, within the population of MoT-cultured D2A1 cells, those cells that successfully
assembled elongated, integrin β1-containing adhesion plaques exhibited a 2.3-fold higher
rate of Ki67 positivity – an indicator of proliferation – than did those that failed to form such
plaques (Supplementary Fig. S5A). Hence, the development of such plaques and the
associated more intense activation of FAK were correlated with and possibly critical to the
rapid proliferation of D2A1 cells under MoT conditions.
We wished to extend these observations to understand the behavior of cells in vivo within
the post-extravasation lung parenchyma. Thus, in order to analyze the formation of integrin
β1-containing, elongated adhesion plaques by the extravasated D2A1 cells, we used two
different types of fluorescent fusion proteins: integrin α5-YPet and α-actinin-Tag-RFP-T
(Supplementary Fig. S7A; refs. 16, 17). Similarly constructed fluorescent marker proteins
had been used successfully by others to monitor the localization of integrin α5 and α-actinin
in cells that were growing in monolayer culture (18).
Integrin α5 associates exclusively with integrin β1 to form heterodimeric integrin receptors,
which are localized specifically to the elongated adhesion plaques in the MoT-cultured
D2A1 cells (ref. 10; Supplementary Figs. S5B and S7B). Moreover, this integrin contributed
critically to the proliferation of the D2A1 cells not only under the MoT culture conditions
but also following the extravasation of these cells into the lung parenchyma (ref. 10;
Supplementary Fig. S7C). These observations justified the use of integrin α5-YPet to
visualize integrin β1-containing, elongated adhesion plaques by the D2A1 cells within the
lung parenchyma. The actin-bundling α-actinin is one of the major components of the
adhesion plaques formed in cells propagated under monolayer culture conditions as well as
of those formed by the MoT-cultured D2A1 cells (ref. 19; Supplementary Fig. S5C). The
combined use of these two fluorescent fusion proteins allowed us to verify that the observed
plaques containing integrin α5-YPet also recruited α-actinin and thus were functional.
Within the lung parenchyma, we found that the aggressive D2A1 cells formed abundant
integrinα5-YPet- and α-actinin-TagRFP-T-containing elongated adhesion plaques; these
first became apparent 5 days after the intravenous injection of these cells. In contrast,
echoing behavior observed in MoT cultures, plaques of this type were rarely formed by the
more indolent D2.0R or D2.1 cells (Fig. 1C and Supplementary Fig. S4). Collectively, these
various observations indicated that the abilities of various D2 cell populations to form
elongated, mature adhesion plaques varied in concert with their abilities to activate FAK
after extravasating into the lung parenchyma (Fig. 1C and Supplementary Fig. S3A). This
suggested, in turn, that these elongated fusion plaques contribute functionally to the more
potent activation of FAK in the aggressive D2A1 cells, which in turn facilitate ERK
phosphorylation and thereby permit the rapid proliferation of these cells in the lung
parenchyma.
Cytoskeletal protrusions that precede the appearance of elongated adhesion plaques
We undertook to uncover the mechanism(s) responsible for the differing abundance of
integrin β1-containing, elongated adhesion plaques among the various D2 cell populations
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(Fig. 1C). To do so, we first studied the temporal development of these plaques in the MoT-
cultured D2A1 cells by monitoring the localization of integrin β1 together with that of actin
cytoskeleton, whose dynamics is coupled tightly with the assembly of adhesion plaques
(15).
Under the MoT culture conditions, the D2A1 cells began to exhibit integrin β1-containing,
elongated plaques earlier than they did so in the lung parenchyma: these plaques became
apparent as early as 24 hours after starting the culture (Fig. 2A). We also found prominent
protrusions displaying integrin β1 that were colocalized with thin bundles of filamentous
actin at this time (Figs. 2A–2C). These protrusions morphologically resembled filopodia –
finger-like protrusions composed of parallel bundles of actin fibers; filopodium formation
has been intensively studied in cells propagated as a monolayer (20, 21). These integrin β1-
containing, filopodium-like protrusions (hereafter referred to as FLPs) appeared as early as 6
hours after introducing the D2A1 cells into MoT culture (Fig. 2A).
In contrast to this behavior of the aggressive D2A1 cells, the metastasis-deficient D2.0R and
D2.1 cells extended far fewer FLPs in MoT cultures (Fig. 2D and Supplementary Fig. S8A).
Importantly, these differing abilities to form FLPs could also be observed in the lung tissue
two days after the intravenous injection of these various D2 cell populations, where FLPs
were visualized by a fluorescent actin marker lifeact-TagRFP-T (ref. 22; Fig. 2E and
Supplementary Fig. S8A). These observations paralleled the differing abilities of these cell
types to assemble integrin β1-containing, elongated adhesion plaques that were observed
both under MoT culture conditions and in the lung parenchyma (Fig. 1C). Together, these
correlations prompted us to hypothesize that the formation of FLPs and the assembly of
elongated adhesion plaques are functionally interrelated in cells growing under both
conditions.
We then explored whether other types of metastasis-competent cells also form FLPs and
elongated adhesion plaques resembling those observed in the aggressive D2A1 cells. Thus,
we examined various human breast cancer cell lines that show differing metastatic powers
upon implantation into mice. Twelve hours after being cultured under MoT conditions, 7 out
of the 9 types of metastatic cells, but none of the 9 types of nonmetastatic cells, exhibited
one or more FLP per cell (Fig. 3A). Moreover, after 5 days of MoT culture, 7 out of 9
metastatic cells, but none of the 9 nonmetastatic cells, exhibited a significant proportion of
cells (> 5% of cell population) that had developed integrin β1-containing, elongated
adhesion plaques (Fig. 3B). Hence, under in vitro MoT culture conditions, a variety of
metastasis-competent cells developed both FLPs and elongated adhesion plaques far more
frequently than did the metastasis-deficient cells.
In addition, following extravasation into the lung parenchyma in vivo, the metastasis-
competent breast cancer cell lines Sum159, BT549, MDA-MB-231 and Sum1315 developed
far more abundant FLPs (> 3.6-fold increase in FLP number per cell on average) and
assembled elongated adhesion plaques far more frequently (by > 30-fold larger proportion of
cell populations on average) than did the metastasis-deficient SKBR3 and ZR-75-1 cells
(Figs. 3C, 3D, Supplementary Figs. S8B and S8C). These extensive correlations between
metastasis competence on the one hand, and the ability to form FLPs and elongated adhesion
plaques on the other, provided additional confirmation of the notion that the formation of
these structures provides critical support for the subsequent development of macroscopic
metastases. However, it still remained unclear whether and how the formation of FLPs
contributes to the subsequent assembly of elongated adhesion plaques.
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Functional connection between FLP formation and adhesion plaque assembly
The model proposed here – that FLPs are involved in the formation of elongated, mature
adhesion plaques – contrasted with the widely accepted view of the process of mature
adhesion plaque formation in cells that are propagated as monolayers in vitro. Thus, the
majority of mature adhesion plaques in monolayer-cultured cells are thought to be formed
independently of filopodia, i.e., the actin-rich protrusions that morphologically resemble
FLPs. Indeed, these adhesion plaques have been found to originate largely from dot-like
focal complexes formed beneath lamellipodia – sheet-like protrusions that are
morphologically and functionally distinct from filopodia (15) – in monolayer-cultured cells.
Importantly, lamellipodial protrusions were rarely observed when cells were propagated
within the 3D gels (23), although the formation of elongated, mature adhesion plaques were
repeatedly observed in various cell types propagated within such gels (reviewed in ref. 24).
These observations by others, together with our present observations of FLPs, led us to
speculate that certain types of 3D-cultured cells employ an FLP-mediated mechanism of
mature adhesion plaque formation instead of relying on the lamellipodium-dependent
mechanism.
In order to elucidate the connection between FLPs and elongated adhesion plaques, we
asked whether FLPs interact with the proteins involved in cell-ECM adhesions in a way
different from filopodia formed by monolayer-cultured cells (Figs. 4A–4C, Supplementary
Figs. S9A–D, Supplementary Movies S1 and S2). We found that integrin β1 was distributed
along the length of the shafts of FLPs in the MoT-cultured D2A1 cells (Fig. 4A). In contrast,
confirming previous observations by others (25, 26), integrin β1 was enriched at the tips of
filopodia in the D2A1 cells growing as a monolayer (Fig. 4A). These observations were
consistent with the notion that FLPs contribute to the formation of integrin-mediated
adhesions in a manner different from filopodia.
We proceeded to analyze the association with FLPs of major adhesion plaque proteins —
FAK, talin1 and paxillin. We found that these adhesion plaque proteins were recruited
progressively to FLPs in the MoT-cultured D2A1 cells (Fig. 4D, Supplementary Figs. S10A
and S10B). These results, together with the temporal order of FLP formation prior to the
assembly of elongated adhesion plaques (Fig. 2A), indicated that the protein components of
these plaques, including integrin subunits (e.g., β1) and adhesion plaque proteins (e.g., FAK,
talin1 and paxillin), first accumulate in FLPs prior to their association with elongated
adhesion plaques.
To directly observe the relationship between FLP formation and elongated adhesion plaque
assembly, we performed time-lapse microscopy analyses on the integrin α5-YPet-expressing
D2A1 cells growing in MoT culture. We found that among a group of 235 cells that did not
display elongated adhesion plaques at the beginning of observation, 129 (55%) cells
exhibited the formation of FLPs either at the beginning or during the course of the
observation period, while the remaining 106 (45%) cells never developed FLPs (Fig. 4E).
Notably, 61 out of the 129 FLP-forming cells, but none of the 106 FLP-non-forming cells,
eventually developed elongated adhesion plaques.
This correlation strongly suggested that FLP formation is a prerequisite for the development
of elongated adhesion plaques in these cells. Moreover, with increasing time, we observed
the progressive centripetal movement of the FLP-associated integrin α5-YPet complexes (0–
80 min; Fig. 4F and Supplementary Movie S3). This ultimately resulted in the translocation
of these complexes into elongated adhesion plaques that were aligned with the cell surface
(140–160 min; Fig. 4F and Supplementary Movie S3). Hence, the cluster of integrins
displayed along the lengths of FLPs, presumably together with associated adhesion plaque
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proteins, served as precursors of those that accumulate in elongated, mature adhesion
plaques. Collectively, these observations prompted us to postulate that FLPs contribute to
the assembly of mature adhesion plaques by fostering the nucleation of protein complexes
that comprise the core of these plaques.
Rif/mDia2 signaling in FLP formation and metastatic colonization
The findings described above demonstrated that the rapid proliferation of cancer cells under
MoT culture conditions in vitro and within the lung parenchyma in vivo is preceded by a
series of changes that are initiated by the formation of FLPs. Thus, under these conditions,
FLP formation appeared to contribute critically to the assembly of elongated, mature
adhesion plaques, which in turn triggers FAK/ERK signaling and thereby ultimately permits
rapid cell proliferation.
In order to confirm the causal contribution of these initial steps, we undertook to test the
effects of blocking FLP formation. A number of proteins, notably Cdc42, fascin1, Rif,
mDia2, IRSp53, myosin X and Ena/VASP, have been associated with the formation of
filopodia in monolayer-cultured cells (21); the last of these subsumes a group of three actin-
binding proteins – Mena, VASP and Evl (27). Based on the structural similarity between
filopodia and FLPs (Figs. 4A and 4B), we speculated that some of these regulators of
filopodia also contribute to the formation of FLPs in cells growing under MoT culture
conditions. Accordingly, we proceeded to examine the involvement of these proteins in FLP
formation.
We found that the knockdown of Cdc42, Rif, mDia2 or myosin X expression, as well as the
functional inhibition of Ena/VASP proteins by the VASP-TD fragment – a dominant-
negative inhibitor for all three Ena/VASP proteins (28) –, both resulted in significant (42–
61%) decreases in the number of FLPs formed by MoT-cultured D2A1 cells. These
decreases in FLP number were associated with 42–90% reductions in cell number when
these cells were propagated for 10 days under MoT conditions, whereas none of these
manipulations caused more than 13% decrease in cell number when these cells were
propagated as monolayers for the same period of time (Figs. 5A, 5B and Supplementary
Figs. S11A–F). In contrast, knocking down the expression of either fascin1 or IRSp53,
neither of which participated in FLP formation in the D2A1 cells growing under the MoT
conditions (Fig. 5A), failed to discernibly affect the proliferation of these cells under these
conditions (Fig. 5B). Based on these extensive correlations, we concluded that in the MoT-
cultured D2A1 cells, the formation of FLPs contributes critically to the ability of these cells
to proliferate rapidly.
Among the proteins that were involved in FLP formation in the D2A1 cells, Rif and mDia2
were of particular interest for the following reasons: First, in certain types of monolayer-
cultured cells, the driving force of filopodial protrusion is provided by the mDia2-mediated
actin nucleation and polymerization, which in turn can be activated by a Rho-family GTPase
Rif; this suggested the central role of Rif/mDia2 signaling in the formation of certain types
of filopodia and similar protrusions (29). Second, in the D2A1 cells growing under MoT
conditions, the knockdown of either Rif or mDia2 expression had a more potent effect than
did the knockdown of the other filopodium-regulators tested here on both FLP formation
and proliferation (see Figs. 5A and 5B). Third, Rif was found to be localized along the shafts
of FLPs formed in the MoT-cultured D2A1 cells, while mDia2 was enriched at their tips;
this reflected the distribution patterns of Rif and mDia2 within filopodia extending from
HeLa cells propagated as a monolayer (Fig. 5C; ref. 30). Collectively, these observations
suggested the importance of Rif/mDia2 signaling in enabling the abundant display of FLPs
in the MoT-cultured D2A1 cells.
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These considerations prompted us to analyze in detail the effect of Rif or mDia2 knockdown
on the behavior of the D2A1 cells growing under MoT culture conditions. We found that the
development by these cells of integrin β1-containing, elongated adhesion plaques, as well as
the activation of FAK and ERKs, was significantly impaired by the knockdown of Rif or
mDia2 expression (Figs. 5D and 5E). In contrast, neither of these knockdowns noticeably
affected the activation status of FAK and ERKs when the D2A1 cells were growing as a
monolayer (Fig. 5E). Moreover, the reduced proliferation under MoT culture conditions of
both Rif-knockdown and mDia2-knockdown D2A1 cells was reversed by the concomitant
expression of the constitutively active CD2-FAK in these cells (Fig. 5F and Supplementary
Fig. S11C). Hence, Rif/mDia2-dependent formation of FLPs in cells propagated under MoT
culture conditions contributes to the proliferation of these cells largely, if not entirely, by
promoting the assembly of integrin β1-containing, elongated adhesion plaques, thereby
facilitating FAK activation.
We also examined the role of Rif/mDia2 signaling in the behavior of the D2A1 cells
disseminated within the lungs. The efficiency of extravasation into the lung parenchyma was
not noticeably affected by the knockdown of Rif or mDia2 expression (Supplementary Figs.
S12A and S12B). However, both the Rif-knockdown and mDia2-knockdown cells exhibited
significantly reduced (48–57%) numbers of FLPs compared to the control cells shortly after
these cells had infiltrated into the lung parenchyma (Fig. 6A). This was associated with
impaired development of elongated adhesion plaques, reduced levels of FAK
phosphorylation on Y397 and Y861, as well as decreased proliferation rates (Figs. 6B–6D).
These observations indicated a functional connection between Rif/mDia2-dependent FLP
formation and proliferation in the D2A1 cells that had extravasated into the lung
parenchyma. Importantly, Rif-knockdown and mDia2-knockdown cells ultimately
developed 8.2 to 13.2 fold reduced numbers of macroscopic metastases in the lungs relative
to the control D2A1 cells injected in parallel, as examined 24 days after the injection (Fig.
6D).
We also examined in detail the lung sections that were harvested 10 days after the injection.
Here again, the knockdown of Rif or mDia2 expression in the D2A1 cells decreased (2.5 to
3.9 fold) the numbers of macroscopic metastases (> 20 cells/colony) that were observed in
these sections (Fig. 6E). Interestingly, however, the numbers of microscopic metastases (≤
20 cells/colony), which were composed mostly (> 90%) of viable but nonproliferating cells
(Supplementary Fig. S13A), were actually increased (1.7 to 2.3 fold) by these knockdowns
(Fig. 6E). Collectively, these observations indicated that the knockdown of Rif or mDia2
expression diminishes the ability of the otherwise-aggressive D2A1 cells to proliferate
rapidly following extravasation into the lung parenchyma, thereby forcing these cells to
remain quiescent in the lung tissue without apparently dying or proliferating.
The inhibitory effect of Rif or mDia2 knockdown on macroscopic lung metastasis formation
was also observed following the tail-vein injection of TS/A mouse mammary carcinoma
cells (Supplementary Figs. S11D–S11F and S13B), while these knockdowns did not
discernibly affect the proliferation of these cells in monolayer culture (Supplementary Fig.
S11F). Hence, multiple metastasis-competent cell types rely on Rif/mDia2 signaling for
efficiently colonizing the lung tissue. We also found that the ability of Rif-knockdown and
mDia2-knockdown D2A1 cells to form macroscopic lung metastases could be partially
restored by ectopically expressing the constitutively active CD2-FAK fusion protein in these
cells (Fig. 6F). This supported the role of FAK as a key signaling mediator connecting Rif/
mDia2-dependent FLP formation and the development of macroscopic metastases (Fig. 7A).
We proceeded to further substantiate the causal connection between the formation of FLPs
and proliferation by extravasated cancer cells. To do so, we tested the effects of other
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strategies that simultaneously blocked FLP formation and proliferation in the D2A1 cells
growing under the MoT conditions of culture: these included the knockdown of Cdc42
expression as well as the expression of dominant-negative constructs for the Cdc42 (Cdc42
T17N; ref. 31) or Ena/VASP proteins (VASP-TD) (Figs. 5A, 5B, Supplementary Figs.
S14A-D). Here again, we observed that all three manipulations concomitantly impaired the
FLP-forming ability and proliferation potential of the D2A1 cells that were infiltrated into
the lung parenchyma following tail-vein injection (Figs. 6A, 6D and Supplementary Figs.
S15A–E). Moreover, these manipulated cells ultimately developed 57–72% fewer numbers
of macroscopic lung metastases than did the control cells injected in parallel (Fig. 6D and
Supplementary Fig. S15D), while none of these manipulations noticeably affected the
proliferation of the D2A1 cells in monolayer culture (Fig. 5B and Supplementary Fig. S14C)
In contrast, the knockdown of the expression of fascin1, an actin-bundling protein
dispensable for the formation of FLPs under MoT conditions, also failed to block FLP
formation by the extravasated D2A1 cells in the lung parenchyma (Figs. 5A and 6A).
Moreover, fascin1 knockdown did not noticeably inhibit the proliferation of the D2A1 cells
within the lung tissue (Fig. 6D and Supplementary Fig. S15F). These observations lent
further support to the model that the formation of FLPs by disseminated cancer cells
contributes critically to metastatic colonization.
We also asked whether the enforced activation of Rif or mDia2 in the otherwise-
nonaggressive D2.0R and D2.1 cells enabled them to extend abundant FLPs, thereby
ultimately allowing these cells to proliferate rapidly under MoT culture conditions in vitro
and within the lung parenchyma in vivo (Supplementary Figs. S16A–E and S17A). As
expected, the ectopic expression of the constitutively active mutant of Rif or mDia2 (Rif
Q77L and mDia2 M1041A) enabled the D2.0R and D2.1 cells to form abundant actin-rich
protrusions under MoT conditions of culture, which were morphologically indistinguishable
from FLPs formed naturally by the aggressive D2A1 cells (Supplementary Fig. S16A).
However, these manipulated D2.0R and D2.1 cells subsequently failed to develop abundant,
elongated adhesion plaques containing integrin β1 and they exhibited only modest, if any,
increases in the rate of proliferation under MoT culture conditions relative to the respective
control cells (Supplementary Figs. S16 C and S16D). Moreover, the expression of Rif Q77L
and mDia2 M1041A did not noticeably enhance the ability of the D2.0R and D2.1 cells to
form macroscopic lung metastases following tail-vein injection (Supplementary Fig. S17A).
Collectively, these observations indicated that the formation of FLPs is necessary, but not
sufficient to enable the rapid proliferation of cancer cells under MoT culture conditions in
vitro and within the lung parenchyma in vivo.
The role of Rif/mDia2 signaling in tumor progression
We proceeded to determine whether the proteins that were involved in the formation of
FLPs also contributed to primary tumor formation. Accordingly, we implanted Rif-
knockdown and mDia2-knockdown D2A1 cells orthotopically in mouse mammary fat pads.
We observed that the sizes of the resulting primary tumors were not noticeably affected by
these knockdowns (Fig. 7B). Moreover, the control, Rif-knockdown and mDia2-knockdown
D2A1 cells exhibited comparable rates of proliferation within these established tumors (Fig.
7B).
We also examined the effects of Rif knockdown on the spontaneous metastasis from the
orthotopically implanted tumors generated by TS/A cells, which usually spawn large
numbers of metastases in both the lungs and liver. As was the case with D2A1 cells, the
orthotopically-implanted control and Rif-knockdown TS/A cells yielded primary tumors of
similar sizes, within which these cells exhibited comparable proliferation rates regardless of
the knockdown of Rif expression (Fig. 7C and Supplementary Fig. S17B). In contrast, Rif
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knockdown led to substantially decreased numbers of macrometastases spawned by the TS/
A primary tumors, not only in the lungs (81–92% decrease) but also in the liver (87–100%)
(Fig. 7C and Supplementary Fig. S17B).
These observations pointed to a profound difference in the mechanisms governing the
proliferation of cancer cells within already-established primary tumors and shortly after
extravasating into the parenchyma of foreign tissues. Thus, the Rif- and mDia2-dependent
mechanism of FLP formation is dispensable for the proliferation of cancer cells within the
established primary tumors. However, it represents an important mechanism employed by
cancer cells to enable their proliferation soon after these cells directly confront the ECM
environment within the foreign tissue parenchyma, specifically those of the lungs and liver
(Fig. 7A).
We extended these findings by inhibiting FLP formation in B16F10 mouse melanoma cells
(32), which efficiently generate macroscopic metastases in various organs following
intracardiac injection (33). We found that macrometastasis formations by the intracardially-
injected B16F10 melanoma cells in the lungs, liver and bone marrow, were all significantly
impaired by the knockdown of Rif expression in these cells (Fig. 7D). In contrast, the
growth of primary tumors following subcutaneous implantation of the B16F10 cells were
not noticeably affected by this knockdown (Supplementary Fig. S17C). These results
supported the notion that Rif, and presumably other proteins involved in the formation of
FLPs, contribute in critical ways to the establishment of macroscopic metastases in multiple
target organs.
Discussion
Systemic dissemination of cancer cells is frequently observed in both breast and prostate
cancer patients. However, the numbers of disseminated cells clearly dwarf those of
successfully formed metastases (34), provoking the question of why metastatic colonization
is so inefficient. Clearly, enormous attrition of cancer cells occurs in the interval between
the lodging of disseminated cells in microvessels and the establishment of macroscopic
metastases (35).
We postulate that at least three impediments obstruct the path toward successful metastasis
formation. First, cancer cells must enter the parenchyma of a foreign tissue, either by
invading through capillaries walls or by proliferating intraluminally and then rupturing the
endothelium. Second, they must survive and initiate proliferation by establishing productive
connections with the parenchymal ECM. Third, they must adapt to unfamiliar growth factor
and cytokine environments in order to acquire mitogenic and trophic signals (36). Here we
have studied the second of these processes – how disseminated cells initiate proliferation
after confronting the ECM environment of a foreign tissue parenchyma.
The findings presented here collectively prompt us to propose that in certain and perhaps
many types of metastatic cells, the chain of processes governing the initial proliferation of
cancer cells within the post-extravasation tissue parenchyma can be depicted as follows:
formation of filopodium-like protrusions (FLPs) containing integrin β1 along the length of
their shafts → recruitment of adhesion plaque proteins to these integrin β1-containing FLPs
→ assembly of elongated, mature adhesion plaques following the centripetal movement of
integrin clusters → FAK activation within these mature adhesion plaques → FAK-
dependent activation of ERKs → cell proliferation (Fig. 7A).
The FLPs that enabled the rapid proliferation of extravasated cancer cells morphologically
resemble filopodia extended by monolayer-cultured cells: both are actin-rich protrusions
exhibiting finger-like shapes. However, there are also important distinctions between
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filopodia and FLPs. Thus, while integrin β1 is enriched at the tips of filopodia, this integrin
subunit was found to be distributed evenly along the shafts of FLPs (Fig. 4A). In addition,
we observed a profound difference in the lifetime of these two types of protrusions: while
the 80% of filopodia retracted within 30 minutes after initial extension, the majority (> 90%)
of FLPs survived longer than 60 minutes (Fig. 4C, Supplementary Movies S1 and S2). The
detailed relationship of FLPs to the filopodia formed by monolayer-cultured cells awaits
future study.
The set of cytoskeleton regulatory proteins involved in the formation of FLPs following
extravasation overlaps partially with those that regulate invasiveness, an attribute essential
for completing an earlier step of the invasion-metastasis cascade (37). Thus, Cdc42 and
mDia2, two important regulators of FLP formation (Fig. 5A), are also involved in fibroblast
invasion through collagen matrices and kidney epithelial cell migration, respectively (38,
39). However, we also found considerable differences between the mechanism controlling
invasiveness and the one regulating FLP formation. Thus, the knockdown of Rif expression,
which efficiently blocks the formation of FLPs by the D2A1 cells within the lung
parenchyma, did not noticeably affect their invasiveness through the Boyden chamber (data
not shown). Moreover, FLPs formed under MoT culture conditions are organized differently
from invadopodia – protrusions that are formed by cells propagated above a film of ECM
and are thought to contribute to cancer cell invasiveness (Supplementary Fig. S9B; ref. 40).
This reinforces the notion that cancer cells employ distinct sets of actin-regulating proteins
in executing the different steps of the invasion-metastasis cascade.
By studying further the role of the protein regulators of FLP formation in controlling cancer
cell behaviors, we found that these proteins were dispensable for the continuous
proliferation of cancer cells within already-established primary tumors (Fig. 7B and
Supplementary Fig. S17B). This would suggest, in turn, that during the progression of
primary tumors, the acquired ability to extend abundant FLPs is unlikely to be selectively
advantageous to the cells within these tumors. Moreover, as described above, cancer cell
invasion from the primary tumors appears to be governed by a set of actin-regulating
proteins distinct from those enabling abundant FLP formation. Collectively, these
observations might provide an explanation for the inability of the majority of cancer cells to
initiate proliferation after leaving the primary site and infiltrating into the parenchyma of
foreign tissues, where the ability of FLP formation is indeed critical to the initiation of
proliferation.
The present study leaves several significant issues unresolved. These include the molecular
determinants of the differing abundance of FLPs among the various populations of the D2
cells. In addition, we also found a reduced incidence of primary tumors following the
orthotopic implantation of cells that have been manipulated to block the formation of FLPs.
Thus, manipulations that block FLP formation, including the knockdown of either Rif or
mDia2 expression, as well as the overexpression of the dominant-negative Cdc42 T17N, all
significantly reduced the incidence of primary tumors by orthotopically-implanted D2A1
cells (12 to 1400 fold decreases in the estimated frequency of tumor-initiating cells; data not
shown). This suggests, but does not prove, that the molecular machinery governing the
formation of FLPs in the micrometastatic cancer cells also contributes critically to the initial
establishment of primary tumors after orthotopic implantation of certain types of cancer
cells. These issues will be addressed in a subsequent study.
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Methods
Plasmids
The lentiviral vectors expressing protein-coding DNA sequences used in this study were
generated using pLV-IRES-neo (10), pLV-IRES-puro or pLV-IRES-EGFP as a backbone.
pLKO-puro was used as backbones for the lentiviral vectors expressing short hairpin RNAs
(shRNAs).
Cell culture
Mouse mammary carcinoma D2 cell lines (D2.0R, D2.1 and D2A1) and TS/A cell line were
gifts from FR Miller and PL Lollini, respectively (7, 41). Human mammary carcinoma cell
lines MCF10A, Sum1315, Sum149 and Sum159 were gifts from SP Ethier (42, 43). All
these cells were maintained as described previously (10, 41, 44). Human mammary
carcinoma cell lines BT474, BT549, MCF7, MDA-MB-157, -231, -436, -453, -468, SK-
BR-3, T47D and ZR-75-1, as well as mouse melanoma cell line B16F10, were obtained
from ATCC and maintained according to the provider’s protocol. The preparation and
maintenance of human mammary epithelial cell lines HME, HMLER and BPLER were
described previously (45, 46). The human mammary carcinoma cell lines MCF10A,
Sum149, Sum159, BT474, BT549, MCF7, MDA-MB-157, -231, -453, -468, SK-BR-3 and
T47D, as well as the human mammary epithelial cell lines used here, were authenticated by
microarray analysis. The other human mammary carcinoma cell lines, as well as the mouse
cell lines used here, were not passaged more than 6 months after receipt.
Statistical Analysis
Statistical analyses were carried out by Student’s t-test, unless otherwise indicated.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Significance
While the mechanisms of metastatic dissemination have begun to be uncovered, those
involved in the establishment of extravasated cancer cells in foreign tissue
microenvironments remained largely obscure. We have studied the behavior of recently
extravasated cancer cells in the lungs and identified a series of cell-biological processes,
involving the formation of filopodium-like protrusions (FLPs) and the subsequent
development of elongated, mature adhesion plaques, which contribute critically to the
rapid proliferation of the micrometastatic cells and thus are prerequisites to the eventual
lung colonization by these cells.
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Figure 1. Relationship between adhesion plaque formation, FAK/ERK signaling and
proliferation
(A) FAK/ERK signaling and proliferation. Two different shRNA sequences targeting FAK
and MEK1 mutants (dominant-negative MEK1 K97M; constitutively active MEK1-DD)
were tested for their effects on proliferation and ERK phosphorylation under various
conditions. D2A1 cells expressing FLAG-tagged ERK2 (FLAG-ERK) were used to
determine ERK phosphorylation levels in cells disseminated to the lungs. Following tail-
vein injection, lungs were harvested and lysed, from which FLAG-ERK was
immunoprecipitated and analyzed. (ns) p > 0.5, (*) p < 0.02. In ‘pERK blot’, values
represent the ratio of band intensities relative to that of the control sample.
(B) FAK/ERK signaling and lung colonization. D2A1-GFP cells, in which FAK/ERK
signaling was manipulated as indicated, were tail-vein injected into mice. The numbers of
macrometastases in the left upper lobe of the lungs (bottom) and representative lobe images
(top) are presented. The red bars represent the mean values. MEK1-DD expression restored
the proliferation of FAK-knockdown D2A1 cells (see A), allowing them to form abundant
macrometastases; this substantiated the role of ERKs as major effectors of FAK in
regulating colonization. (ns) p > 0.5, (*) p < 0.001.
(C) Formation of integrin β1-containing, elongated adhesion plaques. D2 cells growing in
MoT cultures were stained for integrin β1 (red; with an active-conformation-specific
antibody, 9EG7) and nuclei (DAPI: blue) (top-left). D2 cells expressing integrin α5-YPet
(green) and α-actinin-TagRFP-T (red) were tail-vein injected into mice and the distributions
of these fluorescent fusion proteins and nuclei (Hoechst 33342; blue) were determined on
Shibue et al. Page 16
Cancer Discov. Author manuscript; available in PMC 2013 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
lung sections (bottom-left). The presence of elongated adhesion plaques was quantified
(right).
(D) FAK phosphorylation levels associated with different integrin β1-containing structures.
MoT-cultured D2A1 cells were dually stained for pFAK (or total FAK) and integrin β1.
Representative images of ‘elongated adhesion plaques’ and ‘peripheral accumulations’ with
pFAK [Y397] (green)/integrin β1 (red) staining as well as pseudocolored images representing
the ratio of fluorescence intensities are presented (top). The ratio of fluorescence intensities
within the region drawn around each of these structures was plotted (n = 50; bottom). (*) p <
1 × 10−9.
Bars = 2 mm (B), 10 μm (C,D). Values = means ± SD (n = 3; A,C).
Shibue et al. Page 17
Cancer Discov. Author manuscript; available in PMC 2013 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2. Filopodium-like protrusions that precede adhesion plaque assembly
(A) Temporal development of elongated adhesion plaques. The localization of integrin β1
(red), F-actin (phalloidin; green) and nuclei (blue) was determined at indicated time points
in the MoT-cultured D2A1 cells (left). Integrin β1-containing protrusions (orange
arrowheads), elongated adhesion plaques (pink arrows), protrusions of F-actin (blue
arrowheads), and actin stress fibers (green arrows) are indicated. The presence of these
structures was quantified (right).
(B) Upward and downward projections of FLPs. Top and side views of the MoT-cultured
D2A1 cells with F-actin-staining (green) are presented with indication of FLPs by the pink
arrowheads.
(C) Localization of integrin subunits to FLPs. MoT-cultured D2A1 cells were stained for
integrin subunits (red), F-actin (green) and nuclei (blue) (left). The accumulation of these
subunits to FLPs is indicated (blue arrowheads). The probability with which the length of
FLP shaft was covered by the integrin staining was plotted (right).
(D) FLP formation in MoT-cultured D2 cells. Integrin β1-containing FLPs are indicated by
the yellow arrowheads (top). The number of FLPs per cell was plotted (bottom).
(E) In vivo FLP formation. D2 cells expressing lifeact-Tag-RFP-T (red) and integrin α5-
YPet (green) were tail-vein injected into mice. Blood vessels (PECAM-1-staining; white)
and nuclei (blue) were visualized together with these fluorescent proteins on lung sections,
where FLPs are indicated (blue arrowheads). These cells are not surrounded by the
PECAM-1-staining and therefore are likely to have extravasated into the lung parenchyma.
The number of FLPs per cell was plotted (bottom-right).
Bars = 10 μm. Values = means ± SD (n = 3; A,C) or means ± SEM (n = 100; D,E).
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Figure 3. Formation of FLPs and elongated adhesion plaques by various human breast cancer
cell lines
(A,B) In vitro formation of FLPs and adhesion plaques. Cells were cultured under MoT
conditions to quantify the formation of FLPs (A) and elongated adhesion plaques (B). In B,
integrin β1 (red) was stained with an active-conformation-specific antibody, HUTS-21. (*) p
= 0.004, (**) p = 0.02.
(C,D) In vivo formation of FLPs and adhesion plaques Cells were engineered to express
integrin α5-YPet (green) and either of lifeact-Tag-RFP-T (red; C) or α-actinin-Tag-RFP-T
(red; D). These cells were tail-vein injected into mice to test the formation of FLPs (C) and
elongated adhesion plaques (D) within the lung parenchyma. (*) p = 0.0005, (**) p =
0.0008.
Bars = 10 μm. Values = means ± SEM (n = 100; A,C) or means ± SD (n = 3; B,D).
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Figure 4. FLP formation as a prerequisite for adhesion plaque assembly
(A–C) Comparison of filopodia (monolayer) and FLPs (MoT). Cells growing in either
monolayer or MoT culture were stained for F-actin (green; A,B), integrin β1 (red; A) and α-
actinin (red; B, bottom). Fascin1 localization was determined by the use of TagRFP-T-
fascin1 fusion protein (red; B, top). In A, the fluorescence intensity along the line (root [R] –
tip [T]) was plotted (right) and integrin β1 distribution within each protrusion types was
scored (bottom). In B, fascin1 was localized along the length of filopodia but not to FLPs;
α-actinin was detected at the root of filopodia and along the length of FLPs. In C, the
kinetics of the assembly and disassembly of these protrusions are represented by the Kaplan-
Meier survival curves. D2A1 cells expressing the lifeact-YPet actin marker were analyzed
by time-lapse microscopy. (*) p < 0.0001 (by log-rank test).
(D) Initial accumulation of adhesion plaque proteins to FLPs. The localization of F-actin
(green), nuclei (blue) and FAK (red) was determined at indicated time points (top). The
pseudocolored images represent the profiles of FAK-staining intensity. The accumulation of
integrin β1 and various adhesion plaque proteins to FLPs and elongated adhesion plaques
was scored (bottom).
(E,F) Functional connection between FLPs and elongated adhesion plaques. Integrin α5-
YPet-expressing D2A1 cells growing under the MoT conditions were analyzed by time-
lapse microscopy. In E, cells were classified by the presence or absence of FLPs (purple)
and elongated adhesion plaques (green) at the beginning of observation. Initially-adhesion-
plaque-negative cells (113 + 122 cells) were analyzed for the subsequent development of
FLPs and elongated adhesion plaques. In F, an example of progressive inward movement of
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FLP-associated integrin α5-YPet clumps (arrowheads; 0–80 min) and subsequent outward
extension of the plasma membrane, which cooperatively converted these integrin clumps
into the ones constituting elongated adhesion plaques (arrowheads; 140–160 min), is
presented. The pink dotted lines represent cell edges.
Bars = 10 μm. Values = means ± SD (n = 3; A) or means ± SEM (n = 30; D).
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Figure 5. Identification of the molecular regulators of FLP formation
(A,B) Screening of filopodium regulators for their involvement in FLP formation and
proliferation. D2A1 cells, manipulated to block the expression or function of filopodium-
associated proteins, were tested for FLP formation under MoT culture conditions (A). Two
different shRNA sequences were tested for each knockdown targets. The effects of these
manipulations on the cell number after 10 days of monolayer or MoT cultures were also
tested (B). (ns) p > 0.2, (*) p < 0.02 (vs control).
(C) Localization of Rif and mDia2 to FLPs. YPet-Rif fusion protein was used for analyzing
Rif distribution, whereas mDia2 localization was determined by direct immunostaining
(green; mDia2 localization at FLP tips is indicated by pink arrowheads). F-actin (red) and
nuclei (blue) were also visualized.
(D) Role of Rif/mDia2 signaling and Ena/VASP proteins in adhesion plaque formation.
Some of the engineered D2A1 cells described in A were cultured under MoT conditions.
The presence of integrin β1-containing, elongated adhesion plaques was quantified (right).
(ns) p > 0.05, (*) p < 0.0005.
(E) Role of Rif/mDia2 signaling in FAK/ERK activation. Lysates from the indicated cell
types were immunoprecipitated with an anti-total FAK antibody and analyzed for FAK
phosphorylation levels. These lysates were also analyzed by direct immunoblotting for ERK
phosphorylation levels.
(F) Rescue of proliferation defects by CD2-FAK expression. The control, Rif-knockdown
and mDia2-knockdown D2A1 cells were further engineered to express the constitutively
active CD2-FAK fusion protein. Cell numbers after 10-day-culture were plotted. (ns) p >
0.1, (*) p < 0.005.
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Bars = 10 μm. Values = means ± SEM (n = 100; A) or means ± SD (n = 3; B,D,F).
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Figure 6. Rif/mDia2 signaling and lung colonization
(A,B) Rif/mDia2 signaling and in vivo formation of FLPs and elongated adhesion plaques.
D2A1 cells expressing integrin α5-YPet (green) and either of lifeact-Tag-RFP-T (red; A) or
α-actinin-Tag-RFP-T (red; B) were further engineered as indicated and tested for the
formation of FLPs (blue arrowheads; A) and elongated adhesion plaques (pink arrowheads;
B) within the lung parenchyma. The number of FLPs per cell (A, right) and the presence of
elongated adhesion plaques (B, right) were quantified (right). (ns) p > 0.1, (*) p < 1 × 10−8,
(**) p < 0.01.
(C) Rif/mDia2 signaling and in vivo FAK activation. D2A1 cells expressing HA-tagged
FAK (FAK-HA), with or without Rif- or mDia2-knockdown, were tail-vein injected into
mice. Lysates were prepared from the lungs, from which FAK-HA was immunoprecipitated
and analyzed.
(D,E) Rif/mDia2 signaling and lung colonization following tail-vein injection. In D, the
D2A1-GFP cells, engineered as in A, were tested for macrometastasis formation and
proliferation in the lungs. (ns) p > 0.5, (*) p < 0.0002, (**) p < 0.05, (***) p < 0.005. In E,
lung sections were prepared 10 days after the injection of the engineered D2A1 cells, also
expressing membrane-targeted tdTomato (tdTomato-membrane). The numbers of
macroscopic (> 20 cells/colony) and microscopic (≤ 20 cells/colony) metastases were
plotted (bottom). ‘M’-labeled regions indicate macrometastases. (*) p < 0.02, (**) p < 0.05.
(F) Restoring metastasis-forming ability by CD2-FAK expression. The effects of CD2-FAK
expression on the number of lung macrometastases formed by the control, Rif-knockdown
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and mDia2-knockdown D2A1 cells following tail-vein injection were tested. (ns) p > 0.1,
(*) p < 0,005.
Bars = 10 μm (A,B), 2 mm (D,F), 0.1 mm (E). Values = means ± SEM (n = 150; A) or
means ± SD (n = 3; B,D,E).
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Figure 7. Rif/mDia2 signaling in primary tumor formation and spontaneous metastasis
(A) Cell-biological and associated signaling events critical to the initial proliferation of
cancer cells within foreign tissue parenchyma.
(B,C) Role of FLP-regulating proteins in primary tumor formation and spontaneous
metastasis. The D2A1-GFP cells (B) and TS/A-GFP cells (C), each engineered as indicated,
were implanted into mouse mammary fat pads. Subsequent formation of primary tumors and
the incidences of spontaneous metastases in the lungs and liver were analyzed. In B, Ki67-
staining positivity was scored on the primary tumor sections (right). Values = means ± SD
(n = 3). In C, a macrometastasis and micrometastases were indicated by blue and pink
arrowheads, respectively, on the representative lung images (right). (*) p < 0.04, (**) p =
0.03 (vs control) by Fisher’s exact test. (ns) p > 0.2, (***) p < 0.05 by Student’s t-test.
(D) Role of Rif in metastasis formation by the intracardially-injected B16F10 cells. The
control and Rif-knockdown-B16F10 cells were intracardially injected into mice. Metastasis
formation in the lungs, liver and bone marrow was analyzed. (*) p < 0.05 (vs sh scrambled)
by Fisher’s exact test. (**) p < 0.02 by Student’s t-test.
Bars = 0.1 mm (B), 2 mm (C [low mag.], D), 0.5 mm (C [high mag.]).
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